Objective: Chronic kidney disease (CKD) is considered to be one of the most common risk factors for cardiovascular diseases. Glomerular filtration rate (GFR) is the best method of testing level of kidney function and determining stage of kidney disease. The aim of this study was to examine the impact of renal function on severity of coronary heart disease (CHD).
C ardiovascular diseases are the leading cause of death worldwide in end-stage renal disease (ESRD) populations. In patients with chronic kidney disease (CKD), cardiovascular risk is, at least in part, mediated by vascular stiffening. However, cardiovascular risk is not limited to ESRD, and risk of cardiovascular mortality begins to increase with even mild impairment of renal function. [1] Decreased renal function is associated with higher incidence of atherosclerotic process and mortality from cardiovascular disorders. [2] Estimated glomerular filtration rate (eGFR) is a widely accepted, useful, easily calculated, and reproducible parameter used to assess renal functional status. It has been reported that eGFR is more useful than serum creatinine as a predictor of outcomes. [3] The aim of this study was to investigate the relationship between angiographic severity, complexity of coronary heart disease (CHD) and eGFR, which was calculated according to Modification of Diet in Renal Disease (MDRD) formula. [4] 
METHODS
The sample was derived from a population of 1,321 consecutive patients who underwent coronary angiography due to positive noninvasive stress test. In total, 403 were excluded because they met the exclusion criteria (n=314) and did not fulfill the inclusion criteria (n=89). Finally, 918 patients were enrolled, with 563 male (61.3%) and 355 female (38.7%) subjects included. The study was approved by the institutional review board and informed consent was obtained from all patients. Inclusion criteria were age (>18 years), coronary angiogram clear enough to enable evaluation of cause of stress-induced chest pain, and patient's consent. Exclusion criteria were current pregnancy, cardiomyopathy, previous myocardial infarction or revascularization procedures, unstable angina pectoris, history of congenital renal disease, and hemodialysis.
Selective coronary angiography was performed by femoral approach using Judkins technique and Innova 3100 angiographic system (General Electric, Buc Cedex, France). Multiple views were obtained, with visualization of the left anterior descending and left circumflex coronary artery in at least 4 projections, and the right coronary artery in at least 2 projections. Coronary angiograms were recorded on compact discs in DICOM format. All angiograms were analyzed by 2 experienced cardiologists blinded to clinical data. Extent and severity of CHD were evaluated according to SYNTAX score, calculated by a program consisting of sequential and interactive self-guided questions. Algorithm consisted of 12 main questions. Total SYNTAX score was composed of individual scores for each lesion with a diameter stenosis of ≥50% in a vessel of ≥1.5 mm in diameter by visual assessment, as previously reported. [5] Patients were divided into 4 groups based on SYNTAX scores: control group (SYNTAX score: 0); mild CHD group (group I; SYN- 
Statistical analysis
Data were analyzed with SPSS software (version 21.0 for Windows; SPSS Inc., Chicago, IL, USA). Normal distribution of variables was verified with Kolmogorov-Smirnov test. Degrees of association between continuous variables were evaluated by Spearman's rank correlation analyses. Comparisons between the groups were performed with Kruskal-Wallis test and Mann-Whitney U test. When needed, binary comparisons among the groups were performed using Conover-Inman test (p<0.05 was considered statistically significant). A chi-square test was used to investigate whether distributions of categorical variables differed within groups. An optimal cutoff value to predict significant CHD by eGFR was determined by receiver operating characteristic analysis, and area under the curve values were determined. Multinomial logistic regression analysis was performed to determine independent risk factors for severity of coronary heart disease (age, sex, diabetes mellitus [DM], hypertension, hyperlipidemia, smoking, and MDRD levels). All variables with p<0.25 in univariate analysis were included in multivariate analysis. Wald test ("Wald" column) was used to determine statistical significance for each independent variable. The extent to which the dependent variable could be explained by independent variables was assessed by Nagelkerke R2. Hosmer-Lemeshow test was used to determine goodness-of-fit of the logistic regression model. Con- (Figure 1 ). According to Spearman's rank correlation analysis, a negative correlation found between eGFR and SYNTAX score was statistically significant (p<0.001, r=-0.268; p<0.001, r=-0.217 in men; p=0.001, r=-0.375 in women). Otherwise, a positive correlation was found between serum creatinine levels and SYNTAX score (p<0.001, r=0.309; p<0.001, r=0.158 in men; p<0.001, r=0.314 in women). In addition, a statistically significant relationship between severity of CHD and eGFR was found (p<0.001; Table 1). Similarly, a statistically significant relationship was found between severity of CHD groups and stage of renal function (p<0.001). A statistically significant reverse correlation between eGFR and age was also found (p<0.001, r=-0.471; Figure 2 ). In diabetic, hypertensive, and hyperlipidemic patients, eGFR was calculated lower (p=0.001, p<0.001, and p=0.005, respectively). After adjustment according to traditional risk factors including age, DM, hypertension, hyperlipidemia, and smoking status, the correlation between eGFR and SYNTAX score maintained its significance (p<0.001, r=-0.142).
A positive correlation was also found between high-density lipoprotein cholesterol levels and eGFR (p=0.010, r=0.088). A significant inverse correlation was determined between SYNTAX score and high- density lipoprotein cholesterol levels (p<0.001, r=-0.217). In multinomial logistic regression analysis, age, sex, DM, hypertension, hyperlipidemia, smoking, and MDRD were covariates. While eGFR (calculated according to MDRD formula) was found to be an independent predictor of severity of CHD; age, sex, DM, hyperlipidemia, and smoking were also found to affect the severity of CHD (Table 2 ). Cutoff 
DISCUSSION
Even mildly reduced kidney function is significantly associated with CHD severity, independent of other traditional CHD risk factors. CKD is associated with accelerated cardiovascular disease risk. Data from large prospective studies supports that cardiovascular diseases remain the most common cause of morbidity and mortality in patients with CKD. [6] It has been reported that there is an additive contribution of impaired renal function to vascular stiffness, even in patients with moderately severe CHD. [7] Inflammation and oxidative stress are key mechanisms in the development of vascular damage in atherosclerotic CHD. [8] Increased vascular stiffness in patients with renal impairment, however, has also been attributed to inflammation, oxidative stress, and renal arterial calcification. [9, 10] Otherwise, besides traditional risk factors, including DM, hypertension, hyperlipidemia, and advanced age, novel risk factors such as endothelial dysfunction, hyperphosphatemia, and hyperparathyroidism are highly prevalent and seem to play a more important role in vascular disease in CKD and ESRD patients, compared with healthy subjects. [11, 12] Prothrombotic factors (increased fibrinogen, decreased plasminogen activator inhibitor, and tissue plasminogen activator) and hyperhomocysteinemia are the other causes and the mechanisms of why coronary atherosclerotic lesions are more common and severe in patients with CKD. [13, 14] However, it is unclear if impairment of renal function leads to acceleration of these mechanisms in patients with atherosclerotic CHD. Previously mild to moderate renal insufficiency has also been shown to be associated with adverse outcome among patients with acute coronary syndrome. [15] [16] [17] Renal dysfunction has proven to be an important determinant of mortality and morbidity in the follow-up of patients who have undergone coronary artery bypass grafting operation or PCI, as well as in the follow-up of those who have suffered from acute coronary syndrome. [18] Some studies have shown an association between renal function and stable CHD. Goodman et al. reported that CHD is common in young adult patients with ESRD. [19] Gradaus et al. have shown that a more rapid progression of atherosclerotic CHD in patients with ESRD is present when compared to patients with normal renal function. [20] Likewise, Henry et al. demonstrated that mild to moderate loss of renal function is strongly associated with an increased risk of cardiovascular mortality. [21] It was recently reported that SYNTAX score was inversely associated with eGFR. [22] Consistent with the literature, in patients with stable CHD, a lower eGFR estimated by MDRD formula was independently associated with higher SYNTAX score in the present study. Although the correlation we have found between eGFR and SYN-TAX score is not strong, its independence from conventional cardiovascular risk factors such as DM, hypertension, hyperlipidemia, smoking, and advanced age is important. Therefore, clinicians should pay more attention to this group of patients with low eGFR. Early stages of renal dysfunction may be the only marker of CHD severity. Alternately, even mild or moderate renal dysfunction may be a pathogenic contributor to the progression of CHD. Therefore, eGFR measured by MDRD formula is an important, simple, effortless, and cost-effective test that should be used more extensively to predict severity of CHD. In addition, to the best of our knowledge, this is the first study to demonstrate that decreased eGFR is associated with treatment modality after coronary angiography. Accordingly, decreased eGFR was often associated with choice of PCI and coronary artery bypass grafting surgery, as patients who underwent invasive treatment procedures had more severe and complex CHD, and further decreased eGFR than the controls. 
